Generic Portal

— Research Explorer

Selective targeting BMP2 and 4 in SMAD4 negative esophageal adenocarcinoma inhibits tumor growth and aggressiveness in preclinical models

Research output: Contribution to journal › Article › Academic › peer-review

DOI

https://doi.org/10.1007/s13402-022-00689-2
Final published version

Members of the Esophageal Adenocarcinoma Study Group Europe (EACSGE)

Original language	English
Pages (from-to)	639-658
Number of pages	20
Journal	Cellular oncology
Volume	45
Issue number	4
Early online date	2022
DOIs	https://doi.org/10.1007/s13402-022-00689-2
Publication status	Published - Aug 2022

Research areas

BMP2, BMP4, SMAD4, anti-BMP antibodies, VHHs, esophageal adenocarcinoma

ID: 25577650